Clinicians have historically used family health history collection as a primary method for identifying actionable disease-risk assessments. However, as large-scale genome screening programs continue to rise in popularity, the scientific community has questioned the efficacy of this traditional method, wondering at the superiority of variants identified by sequencing over family health history in identifying these risks.